Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Rink MR"'
Evaluation of Gremlin-1 as a therapeutic target in metabolic dysfunction-associated steatohepatitis.
Autor:
Horn P; National Institute for Health Research, Biomedical Research Centre at University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham, Birmingham, United Kingdom.; Centre for Liver & Gastrointestinal Research, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.; Department of Hepatology & Gastroenterology, Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum and Campus Charité Mitte, Berlin, Germany.; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charité Digital Clinician Scientist Program, Berlin, Germany., Norlin J; Global Drug Discovery, Novo Nordisk A/S, Maaloev, Denmark., Almholt K; Global Drug Discovery, Novo Nordisk A/S, Maaloev, Denmark., Viuff BM; Global Drug Discovery, Novo Nordisk A/S, Maaloev, Denmark., Galsgaard ED; Global Translation, Novo Nordisk A/S, Maaloev, Denmark., Hald A; Global Research Technologies, Novo Nordisk A/S, Maaloev, Denmark., Zosel F; Global Research Technologies, Novo Nordisk A/S, Maaloev, Denmark., Demuth H; Global Research Technologies, Novo Nordisk A/S, Maaloev, Denmark., Poulsen S; Global Research Technologies, Novo Nordisk A/S, Maaloev, Denmark., Norby PL; Global Research Technologies, Novo Nordisk A/S, Maaloev, Denmark., Rasch MG; Global Research Technologies, Novo Nordisk A/S, Maaloev, Denmark., Vyberg M; Department of Pathology, Copenhagen University Hospital Hvidovre, and Centre for RNA Medicine, Aalborg University Copenhagen, Copenhagen, Denmark., Fleckner J; Global Translation, Novo Nordisk A/S, Maaloev, Denmark., Werge MP; Gastro Unit, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark., Gluud LL; Gastro Unit, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark., Rink MR; Centre for Liver & Gastrointestinal Research, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Shepherd E; Centre for Liver & Gastrointestinal Research, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Northall E; Centre for Liver & Gastrointestinal Research, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Lalor PF; Centre for Liver & Gastrointestinal Research, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Weston CJ; National Institute for Health Research, Biomedical Research Centre at University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham, Birmingham, United Kingdom.; Centre for Liver & Gastrointestinal Research, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Fog-Tonnesen M; Global Drug Discovery, Novo Nordisk A/S, Maaloev, Denmark., Newsome PN; Roger Williams Institute of Liver Studies, Faculty of Life Sciences and Medicine, King's College London and King's College Hospital, London, United Kingdom.
Publikováno v:
ELife [Elife] 2024 Oct 03; Vol. 13. Date of Electronic Publication: 2024 Oct 03.
Autor:
El-Awaisi J; Microcirculation Research Group, Institute of Cardiovascular Sciences, and., Kavanagh DP; Microcirculation Research Group, Institute of Cardiovascular Sciences, and., Rink MR; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom., Weston CJ; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom., Drury NE; Microcirculation Research Group, Institute of Cardiovascular Sciences, and., Kalia N; Microcirculation Research Group, Institute of Cardiovascular Sciences, and.
Publikováno v:
JCI insight [JCI Insight] 2022 Mar 08; Vol. 7 (5). Date of Electronic Publication: 2022 Mar 08.
Autor:
Rink MR; Institute for Virology and Immunobiology, Julius-Maximilians-University Würzburg, Würzburg, Germany.; Centre for Liver and Gastrointestinal Research, Institute of Immunology and Immunotherapy University of Birmingham, Birmingham, United Kingdom., Baptista MAP; Institute for Virology and Immunobiology, Julius-Maximilians-University Würzburg, Würzburg, Germany., Flomm FJ; Centre for Structural Systems Biology, Hamburg, Germany.; Cluster of Excellence RESIST (EXC 2155), Hannover Medical School, Hannover Medical School, Hannover, Germany.; Leibniz Institute for Experimental Virology (HPI), Hamburg, Germany.; Hannover Medical School, Institute of Virology, Hannover, Germany., Hennig T; Institute for Virology and Immunobiology, Julius-Maximilians-University Würzburg, Würzburg, Germany., Whisnant AW; Institute for Virology and Immunobiology, Julius-Maximilians-University Würzburg, Würzburg, Germany., Wolf N; Institute of Organic Chemistry, Julius-Maximilians-University Würzburg, Würzburg, Germany., Seibel J; Institute of Organic Chemistry, Julius-Maximilians-University Würzburg, Würzburg, Germany., Dölken L; Institute for Virology and Immunobiology, Julius-Maximilians-University Würzburg, Würzburg, Germany.; Helmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz-Center for Infection Research (HZI), Würzburg, Germany., Bosse JB; Centre for Structural Systems Biology, Hamburg, Germany.; Cluster of Excellence RESIST (EXC 2155), Hannover Medical School, Hannover Medical School, Hannover, Germany.; Leibniz Institute for Experimental Virology (HPI), Hamburg, Germany.; Hannover Medical School, Institute of Virology, Hannover, Germany.
Publikováno v:
PloS one [PLoS One] 2021 Aug 04; Vol. 16 (8), pp. e0244166. Date of Electronic Publication: 2021 Aug 04 (Print Publication: 2021).
Autor:
Parker R; Liver and Hepatobiliary Unit, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK; Centre for Liver Research, University of Birmingham, Birmingham, UK; National Institute for Alcoholism and Alcohol Abuse, National Institutes of Health, Rockville, MD, USA. Electronic address: richardparker@nhs.net., Kim SJ; National Institute for Alcoholism and Alcohol Abuse, National Institutes of Health, Rockville, MD, USA., Im GY; Mount Sinai Medical Centre, New York, NY, USA., Nahas J; Mount Sinai Medical Centre, New York, NY, USA., Dhesi B; Liver and Hepatobiliary Unit, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Vergis N; Imperial College Healthcare NHS Foundation Trust, UK., Sinha A; Department of Liver Medicine, University Hospitals Bristol NHS Foundation Trust, UK., Ghezzi A; NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and the University Of Nottingham, Nottingham, UK., Rink MR; Centre for Liver Research, University of Birmingham, Birmingham, UK., McCune A; Department of Liver Medicine, University Hospitals Bristol NHS Foundation Trust, UK., Aithal GP; NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and the University Of Nottingham, Nottingham, UK., Newsome PN; Liver and Hepatobiliary Unit, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK; Centre for Liver Research, University of Birmingham, Birmingham, UK., Weston CJ; Centre for Liver Research, University of Birmingham, Birmingham, UK., Holt A; Liver and Hepatobiliary Unit, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Gao B; National Institute for Alcoholism and Alcohol Abuse, National Institutes of Health, Rockville, MD, USA.
Publikováno v:
EBioMedicine [EBioMedicine] 2019 Jul; Vol. 45, pp. 511-518. Date of Electronic Publication: 2019 Jul 03.